1. Home
  2. MRNA vs CTRA Comparison

MRNA vs CTRA Comparison

Compare MRNA & CTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • CTRA
  • Stock Information
  • Founded
  • MRNA 2010
  • CTRA 1989
  • Country
  • MRNA United States
  • CTRA United States
  • Employees
  • MRNA N/A
  • CTRA N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • CTRA Oil & Gas Production
  • Sector
  • MRNA Health Care
  • CTRA Energy
  • Exchange
  • MRNA Nasdaq
  • CTRA Nasdaq
  • Market Cap
  • MRNA 16.0B
  • CTRA 18.1B
  • IPO Year
  • MRNA 2018
  • CTRA 1990
  • Fundamental
  • Price
  • MRNA $34.06
  • CTRA $29.47
  • Analyst Decision
  • MRNA Hold
  • CTRA Strong Buy
  • Analyst Count
  • MRNA 20
  • CTRA 17
  • Target Price
  • MRNA $76.35
  • CTRA $32.63
  • AVG Volume (30 Days)
  • MRNA 10.7M
  • CTRA 7.1M
  • Earning Date
  • MRNA 02-20-2025
  • CTRA 02-20-2025
  • Dividend Yield
  • MRNA N/A
  • CTRA 2.85%
  • EPS Growth
  • MRNA N/A
  • CTRA N/A
  • EPS
  • MRNA N/A
  • CTRA 1.65
  • Revenue
  • MRNA $5,081,000,000.00
  • CTRA $5,499,000,000.00
  • Revenue This Year
  • MRNA N/A
  • CTRA N/A
  • Revenue Next Year
  • MRNA N/A
  • CTRA $35.68
  • P/E Ratio
  • MRNA N/A
  • CTRA $17.85
  • Revenue Growth
  • MRNA N/A
  • CTRA N/A
  • 52 Week Low
  • MRNA $31.94
  • CTRA $22.30
  • 52 Week High
  • MRNA $170.47
  • CTRA $29.95
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 34.88
  • CTRA 77.00
  • Support Level
  • MRNA $33.34
  • CTRA $26.09
  • Resistance Level
  • MRNA $35.68
  • CTRA $26.87
  • Average True Range (ATR)
  • MRNA 2.46
  • CTRA 0.61
  • MACD
  • MRNA -0.75
  • CTRA 0.43
  • Stochastic Oscillator
  • MRNA 12.49
  • CTRA 91.22

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About CTRA Coterra Energy Inc.

Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and NGLs. The company's operations are primarily concentrated in three core operating areas; the Permian Basin in west Texas and southeast New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin in the Mid-Continent region in Oklahoma.

Share on Social Networks: